By Michael Nevradakis, Ph.D. | The Defender | May 19, 2023 Advisers to the U.S. Food and Drug Administration (FDA) on Thursday recommended, by a vote of 10 to 4, that the agency approve Pfizer’s respiratory syncytial virus (RSV) vaccine for pregnant women, despite questions about the vaccine’s safety. During Thursday’s Vaccines and Related Biological Products […]
Source